Cargando…

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis

Macozinone (MCZ) is a tuberculosis (TB) drug candidate that specifically targets the essential flavoenzyme DprE1, thereby blocking synthesis of the cell wall precursor decaprenyl phosphoarabinose (DPA) and provoking lysis of Mycobacterium tuberculosis. As part of the MCZ backup program, we exploited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piton, Jérémie, Vocat, Anthony, Lupien, Andréanne, Foo, Caroline S., Riabova, Olga, Makarov, Vadim, Cole, Stewart T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153800/ https://www.ncbi.nlm.nih.gov/pubmed/30012754 http://dx.doi.org/10.1128/AAC.00681-18

Ejemplares similares

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
por: Richter, Adrian, et al.
Publicado: (2018)

Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
por: Bhutani, Isha, et al.
Publicado: (2015)

OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
por: Hariguchi, Norimitsu, et al.
Publicado: (2020)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
por: Chikhale, Rupesh V, et al.
Publicado: (2014)

Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis
por: Batt, Sarah M., et al.
Publicado: (2023)

New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
por: Lupien, Andréanne, et al.
Publicado: (2020)

Virtual Screening of Small Molecular Inhibitors against DprE1
por: Zhang, Gang, et al.
Publicado: (2018)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties
por: Amado, Patrícia S. M., et al.
Publicado: (2022)

Towards a new combination therapy for tuberculosis with next generation benzothiazinones
por: Makarov, Vadim, et al.
Publicado: (2014)

Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
por: Fan, Dongguang, et al.
Publicado: (2023)

Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
por: Liu, Renhe, et al.
Publicado: (2017)

Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence
por: Chhabra, Sonali, et al.
Publicado: (2021)

Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis
por: Xiang, Wang, et al.
Publicado: (2023)

Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
por: Foo, Caroline S., et al.
Publicado: (2018)

Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
por: Wang, Pengxu, et al.
Publicado: (2021)

DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023)

Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1): challenging target for antitubercular drug discovery
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Synthesis and Structure–Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents
por: Yadav, Veena D., et al.
Publicado: (2023)

Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis
por: de Jesus Lopes Ribeiro, Ana Luisa, et al.
Publicado: (2011)

In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis
por: González-Martínez, Norma Alejandra, et al.
Publicado: (2015)

Identification of hydantoin based Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools
por: Mali, Suraj N., et al.
Publicado: (2022)

Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
por: Ramey, Michelle E., et al.
Publicado: (2023)

Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis
por: Richter, Adrian, et al.
Publicado: (2021)

1-Sulfonyl-3-amino-1H-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure–Activity Relationship
por: Kazakova, Elena, et al.
Publicado: (2023)

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
por: Robertson, Gregory T., et al.
Publicado: (2021)

1-Benzhydryl-4-(4-chlorophenylsulfonyl)piperazine
por: Girisha, H. R., et al.
Publicado: (2008)

Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Decaprenylphosphoryl-β-D-Ribose 2′-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis
por: Crellin, Paul K., et al.
Publicado: (2011)

Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
por: Degiacomi, Giulia, et al.
Publicado: (2019)

Effects of benzothiazinone and ethambutol on the integrity of the corynebacterial cell envelope
por: Meyer, Fabian M., et al.
Publicado: (2023)

DER NEWSLETTER DES DPR
Publicado: (2022)

High resolution CryoEM structure of the ring-shaped virulence factor EspB from Mycobacterium tuberculosis
por: Piton, Jérémie, et al.
Publicado: (2020)

Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b
por: Benjak, Andrej, et al.
Publicado: (2016)

Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors
por: Jiang, Xiangyi, et al.
Publicado: (2023)

A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties
por: El-Kadiry, Abed El-Hakim, et al.
Publicado: (2020)

Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones
por: Madikizela, Balungile, et al.
Publicado: (2021)

Resolution enhancement with deblurring by pixel reassignment (DPR)
por: Zhao, Bingying, et al.
Publicado: (2023)

The past, present and future of RNA respiratory viruses: influenza and coronaviruses
por: Makarov, Vadim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s8j8f3lkq9bg5j42dimio78qvo